BPC-157 and SNRIs (Venlafaxine, Duloxetine): Interaction Risk, Mechanism, and Monitoring At a glance Regulatory status of BPC-157 / not FDA-approved
More recently, in March 2024, Wegovy was This approval followed promising results from novo Nordisks SELECT trial, which followed 17,604 adults with obesity or overweight and cardiovascular disease but no history of diabetes
Understand the cancellation process
In preclinical research, Epithalon is primarily investigated for its proposed ability to stimulate telomerase expression in somatic cells, potentially affecting telomere maintenance and cellular replicative lifespan
As noted by the authors, additional studies will be needed to determine whether similar outcomes are observed in other groups and to further investigate the biological mechanisms involved
The Essentials: A high-quality Multivitamin, Vitamin D, and B12 (especially since some GLP-1 users report lower energy levels)